Dogs leaving the ICU carry a very large multi-drug resistant enterococcal population with capacity for biofilm formation and horizontal gene transfer

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Ghosh, Anuradha ^a   Dowd, Scot E ^b   Zurek, Ludek ^a  

^a KANSAS STATE UNIVERSITY   (United States)

^b Medical Biofilm Research Institute Lubbock   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; CELL SURFACE PROTEIN; CYTOLYSIN; DALFOPRISTIN PLUS QUINUPRISTIN; DNA 16S; DOXYCYCLINE; ENROFLOXACIN; ERYTHROMYCIN; GELATINASE; GENOMIC DNA; GENTAMICIN; LINEZOLID; NITROFURANTOIN; STREPTOMYCIN; TETRACYCLINE; TIGECYCLINE; VANCOMYCIN; ANTIINFECTIVE AGENT; VIRULENCE FACTOR;

AMPLICON; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL LOAD; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; BACTERIUM CONJUGATION; BACTERIUM ISOLATE; BIOFILM; CELL CLONE; COLONY FORMING UNIT; CONTROLLED STUDY; DOG; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; FECES MICROFLORA; GENETIC VARIABILITY; HEALTH HAZARD; HORIZONTAL GENE TRANSFER; HOSPITAL INFECTION; IN VITRO STUDY; INTENSIVE CARE UNIT; MICROBIAL COMMUNITY; MICROBIAL DIVERSITY; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PHENOTYPE; PULSED FIELD GEL ELECTROPHORESIS; PYROSEQUENCING; TREATMENT DURATION; VARIABLE NUMBER OF TANDEM REPEAT; VETERINARY MEDICINE; ANIMAL; ANIMAL DISEASE; BIODIVERSITY; CLUSTER ANALYSIS; DNA SEQUENCE; DOG DISEASE; DRUG EFFECT; ENTEROCOCCUS; FECES; GENETICS; GRAM POSITIVE INFECTION; GROWTH, DEVELOPMENT AND AGING; HUMAN; METABOLISM; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PATHOGENICITY; PHYSIOLOGY; SPECIES DIFFERENCE;

CANIS FAMILIARIS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM;

ANIMALS; ANTI-BACTERIAL AGENTS; BIODIVERSITY; BIOFILMS; CLONE CELLS; CLUSTER ANALYSIS; CONJUGATION, GENETIC; DOG DISEASES; DOGS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; ENTEROCOCCUS; FECES; GENE TRANSFER, HORIZONTAL; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; INTENSIVE CARE UNITS; MICROBIAL SENSITIVITY TESTS; SEQUENCE ANALYSIS, DNA; SPECIES SPECIFICITY; VIRULENCE FACTORS;

EID: 79960449547     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0022451     Document Type: Article

References (95)

1. Herrero I, Fernández-Garayzábal JF, Moreno MA, Domínguez L, (2004) Dogs should be included in surveillance programs for vancomycin-resistant enterococci. J Clin Microbiol 42: 1384-1385.
2. Guardabassi L, Schwarz S, Lloyd DH, (2004a) Pet animals as reservoirs of antimicrobial-resistant bacteria. J Antimicrob Chemother 54: 321-332.
3. Manian FA, (2003) Asymptomatic nasal carriage of mupirocin-resistant, methicillin-resistant Staphylococcus aureus (MRSA) in a pet dog associated with MRSA infection in household contacts. Clin Infect Dis 36: e26-e28.
4. Guardabassi L, Loeber ME, Jacobson A, (2004b) Transmission of multiple antimicrobial-resistant Staphylococcus intermedius between dogs affected by deep pyoderma and their owners. Vet Microbiol 98: 23-27.
5. Frank LA, Kania SA, Kirzeder EM, Eberlein LC, Bemis DA, (2009) Risk of colonization or gene transfer to owners of dogs with methicillin-resistant Staphylococcus pseudintermedius. Vet Dermatol 20: 496-501.
6. Wolfs TF, Duim B, Geelen SP, Rigter A, Thomson-Carter F, et al. (2001) Neonatal sepsis by Campylobacter jejuni: genetically proven transmission from a household puppy. Clin Infect Dis 32: e97-e99.
7. Simjee S, White DG, McDermott PF, Wagner DD, Zervos MJ, et al. (2002) Characterization of Tn1546 in vancomycin-resistant Enterococcus faecium isolated from canine urinary tract infections: evidence of gene exchange between human and animal enterococci. J Clin Microbiol 40: 4659-4665.
8. Bell JA, Kopper JJ, Turnbull JA, Barbu NI, Murphy AJ, et al. (2008) Ecological characterization of the colonic microbiota of normal and diarrheic dogs. Interdiscip Perspect Infect Dis Article ID 149694, 17 pages.
9. Murray BE, (2000) Vancomycin-resistant enterococcal infections. N Engl J Med 342: 710-721.
10. Arias CA, Murray BE, (2008) Emergence and management of drug-resistant enterococcal infections. Expert Rev Anti Infect Ther 6: 637-655.
11. Hidron AI, Edwards JR, Patel J, Horan TC, Sievert DM, et al. (2008) NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol 29: 996-1011.
12. Dzidic S, Bedeković V, (2003) Horizontal gene transfer-emerging multidrug resistance in hospital bacteria. Acta Pharmacol Sin 24: 519-526.
13. Coburn PS, Baghdayan AS, Dolan GT, Shankar N, (2007) Horizontal transfer of virulence genes encoded on the Enterococcus faecalis pathogenicity island. Mol Microbiol 63: 530-544.
14. Damborg P, Sørensen AH, Guardabassi L, (2008) Monitoring of antimicrobial resistance in healthy dogs: first report of canine ampicillin-resistant Enterococcus faecium clonal complex 17. Vet Microbiol 132: 190-196.
15. Damborg P, Top J, Hendrickx APA, Dawson S, Willems RJL, et al. (2009) Dogs are a reservoir of ampicillin-resistant Enterococcus faecium lineages associated with human infections. Appl Environ Microbiol 75: 2360-2365.
16. Jackson CR, Fedorka-Cray PJ, Davis JA, Barrett JB, Frye JG, (2009a) Prevalence, species distribution and antimicrobial resistance of enterococci isolated from dogs and cats in the United States. J Appl Microbiol 107: 1269-1278.
17. Jackson CR, Fedorka-Cray PJ, Davis JA, Barrett JB, Brousse JH, et al. (2009b) Mechanisms of antimicrobial resistance and genetic relatedness among enterococci isolated from dogs and cats in the United States. J Appl Microbiol 108: 2171-2179.
18. Austin DJ, Bonten MJM, Weinstein RA, Slaughter S, Anderson RM, (1999) Vancomycin-resistant enterococci in intensive-care hospital settings: transmission dynamics, persistence, and the impact of infection control programs. Proc Natl Acad Sci USA 96: 6908-6913.
19. Samuelsson A, Jonasson J, Monstein HJ, Berg S, Isaksson B, (2003) Clustering of enterococcal infections in a general intensive care unit. J Hosp Infect 54: 188-195.
20. Kramer A, Schwebke I, Kampf G, (2006) How long do nosocomial pathogens persist on inanimate surfaces? A systematic review. BMC Infect Dis 6: 130.
21. Macovei L, Zurek L, (2007) Influx of enterococci and associated antibiotic resistance and virulence genes from ready-to-eat food to the human digestive tract. Appl Environ Microbiol 73: 6740-6747.
22. Dowd SE, Callaway TR, Wolcott RD, Sun Y, McKeehan T, et al. (2008) Evaluation of the bacterial diversity in the feces of cattle using 16S rDNA bacterial tag-encoded FLX amplicon pyrosequencing (bTEFAP). BMC Microbiol 8: 125.
23. Middelbos IS, Vester Boler BM, Qu A, White BA, Swanson KS, et al. (2010) Phylogenetic characterization of fecal microbial communities of dogs fed diets with or without supplemental dietary fiber using 454 pyrosequencing. PLoS ONE 5: e9768.
24. Schloss PD, Westcott SL, Ryabin T, Hall JR, Hartmann M, et al. (2009) Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl Environ Microbiol 75: 7537-7541.
25. Clinical and Laboratory Standards Institute (2008) Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals. Approved Standard CLSI Document M31-A3, 3rd edition 28 Wayne, Pa Clinical and Laboratory Standards Institute: 1-99.
26. Clinical and Laboratory Standards Institute (2010) Performance standards for antimicrobial susceptibility testing; twentieth informational supplement. CLSI Document M100-S20 30 Wayne, Pa Clinical and Laboratory Standards Institute: 76-79.
27. Ike Y, Tanimoto K, Tomita H, Takeuchi K, Fujimoto S, (1998) Efficient transfer of the pheromone-independent Enterococcus faecium plasmid pMG1 (Gmr) (65.1 kilobases) to Enterococcus strains during broth mating. J Bacteriol 180: 4886-4892.
28. Tendolkar PM, Baghdayan AS, Shankar N, (2006) Putative surface proteins encoded within a novel transferable locus confer a high-biofilm phenotype to Enterococcus faecalis. J Bacteriol 188: 2063-2072.
29. Nannini EC, Pai SR, Singh KV, Murray BE, (2003) Activity of tigecycline (GAR-936), a novel glycylcycline, against enterococci in the mouse peritonitis model. Antimicrob Agents Chemother 47: 529-532.
30. Coque TM, Tomayko JF, Ricke SC, Okhyusen PC, Murray BE, (1996) Vancomycin-resistant enterococci from nosocomial, community, and animal sources in the United States. Antimicrob Agents Chemother 40: 2605-2609.
31. Landman D, Mobarakai NK, Quale JM, (1993) Novel antibiotic regimens against Enterococcus faecium resistant to ampicillin, vancomycin, and gentamicin. Antimicrob Agents Chemother 37: 1904-1908.
32. Qi C, Zheng X, Obias A, Scheetz MH, Malczynski M, et al. (2006) Comparison of testing methods for detection of decreased linezolid susceptibility due to G2576T mutation of the 23S rRNA gene in Enterococcus faecium and Enterococcus faecalis. J Clin Microbiol 44: 1098-1100.
33. Vankerckhoven V, Autgaerden TV, Vael C, Lammens C, Chapelle S, et al. (2004) Development of a multiplex PCR for the detection of asa1, gelE, cylA, esp, and hyl genes in enterococci and survey for virulence determinants among European hospital isolates of Enterococcus faecium. J Clin Microbiol 42: 4473-4479.
34. Macovei L, Zurek L, (2006) Ecology of antibiotic resistance genes: characterization of enterococci from houseflies collected in food settings. Appl Environ Microbiol 72: 4028-4035.
35. Macovei L, Ghosh A, Thomas VC, Hancock LE, Mahmood S, et al. (2009) Enterococcus faecalis with the gelatinase phenotype regulated by the fsr operon and with biofilm-forming capacity are common in the agricultural environment. Environ Microbiol 11: 1540-1547.
36. Hancock LE, Perego M, (2004) The Enterococcus faecalis fsr two-component system controls biofilm development through production of gelatinase. J Bacteriol 186: 5629-5639.
37. Top J, Schouls LM, Bonten MJM, Willems RJ, (2004) Multiple-locus variable-number tandem repeat analysis, a novel typing scheme to study the genetic relatedness and epidemiology of Enterococcus faecium isolates. J Clin Microbiol 42: 4503-4511.
38. Feil EJ, Li BC, Aanensen DM, Hanage WP, Spratt BG, (2004) eBURST: inferring patterns of evolutionary descent among clusters of related bacterial genotypes from multilocus sequence typing data. J Bacteriol 186: 1518-1530.
39. Amachawadi RG, Shelton NW, Jacob ME, Shi X, Narayanan SK, et al. (2010) Occurrence of tcrb, a transferable copper resistance gene, in fecal enterococci of swine. Foodborne Pathog Dis 7: 1089-1097.
40. Pelz RK, Lipsett PA, Swoboda SM, Diener-West M, Powe NR, et al. (2002) Vancomycin-sensitive and vancomycin-resistant enterococcal infections in the ICU: attributable costs and outcomes. Intensive Care Med 28: 692-697.
41. Roberts RR, Hota B, Ahmad I, Scott RD, Foster SD, et al. (2009) Hospital and societal costs of antimicrobial-resistant infections in a Chicago teaching hospital: implications for antibiotic stewardship. Clin Infect Dis 49: 1175-1184.
42. Wassenberg MWM, de Wit GA, van Hout BA, Bonten MJM, (2010) Quantifying cost-effectiveness of controlling nosocomial spread of antibiotic-resistant bacteria: the case of MRSA. PLoS ONE 5: e11562.
43. Umber JK, Bender JB, (2009) Pets and antimicrobial resistance. Vet Clin North Am Small Anim Pract 39: 279-292.
44. Boerlin P, Eugster S, Gaschen F, Straub R, Schawalder P, (2001) Transmission of opportunistic pathogens in a veterinary teaching hospital. Vet Microbiol 82: 347-359.
45. Ogeer-Gyles JS, Mathews KA, Boerlin P, (2006) Nosocomial infections and antimicrobial resistance in critical care medicine. J Vet Emerg Crit Care 16: 1-18.
46. Clooten J, Kruth S, Arroyo L, Weese JS, (2008) Prevalence and risk factors for Clostridium difficile colonization in dogs and cats hospitalized in an intensive care unit. Vet Microbiol 129: 209-214.
47. Black DM, Rankin SC, King LG, (2009) Antimicrobial therapy and aerobic bacteriologic culture patterns in canine intensive care unit patients: 74 dogs (January-June 2006). J Vet Emerg Crit Care 19: 489-495.
48. Simpson JM, Martineau B, Jones WE, Ballam JM, Mackie RI, (2002) Characterization of fecal bacterial populations in canines: effects of age, breed and dietary fiber. Microb Ecol 44: 186-197.
49. Suchodolski JS, Camacho J, Steiner JM, (2008) Analysis of bacterial diversity in the canine duodenum, jejunum, ileum, and colon by comparative 16S rRNA gene analysis. FEMS Microbiol Ecol 66: 567-578.
50. Suchodolski JS, Dowd SE, Westermarck E, Steiner JM, Wolcott RD, et al. (2009) The effect of the macrolide antibiotic tylosin on microbial diversity in the canine small intestine as demonstrated by massive parallel 16S rRNA gene sequencing. BMC Microbiol 9: 210.
51. Teixeira LCRS, Peixoto RS, Cury JC, Sul WJ, Pellizari VH, et al. (2010) Bacterial diversity in rhizosphere soil from Antarctic vascular plants of Admiralty Bay, maritime Antarctica. ISME J 4: 989-100.
52. Ventura M, Canchaya C, Tauch A, Chandra G, Fitzgerald GF, et al. (2007) Genomics of Actinobacteria: tracing the evolutionary history of an ancient phylum. Microbiol Mol Biol Rev 71: 495-548.
53. Mentula S, Harmoinen J, Heikkila M, Westermarck E, Rautio M, et al. (2005) Comparison between cultured small-intestinal and fecal microbiotas in Beagle dogs. Appl Environ Microbiol 71: 4169-4175.
54. Sghir A, Gramet G, Suau A, Rochet V, Pochart P, et al. (2000) Quantification of bacterial groups within human fecal flora by oligonucleotide probe hybridization. Appl Environ Microbiol 66: 2263-2266.
55. Scallan E, Hoekstra RM, Angulo FJ, Tauxe RV, Widdowson MA, et al. (2011) Foodborne illness acquired in the United States- major pathogens. Emerg Infect Dis [Epub ahead of print] DOI: 10.3201/eid1701.P11101.
56. Devriese LA, Van De Kerckhove A, Kilpper-Bälz R, Schleifer KH, (1987) Characterization and identification of Enterococcus species isolated from the intestines of animals. Int J Syst Bacteriol 37: 257-259.
57. Devriese LA, Colque JIC, De Herdt P, Haesebrouck F, (1992) Identification and composition of the tonsillar and anal enterococcal and streptococcal flora of dogs and cats. J Appl Microbiol 73: 421-425.
58. Graef EM, Devriese LA, Baele M, Vancanneyt M, Swings J, et al. (2005) Identification of enterococcal, streptococcal and Weissella species in the faecal flora of individually owned dogs. J Appl Microbiol 99: 348-353.
59. Kim SY, Adachi Y, (2007) Biological and genetic classification of canine intestinal lactic acid bacteria and bifidobacteria. Microbiol Immunol 51: 919-928.
60. Butaye P, Devriese LA, Haesebrouck F, (2001) Differences in antibiotic resistance patterns of Enterococcus faecalis and Enterococcus faecium strains isolated from farm and pet animals. Antimicrob Agents Chemother 45: 1374-1378.
61. Poeta P, Costa D, Rodrigues J, Torres C, (2006) Antimicrobial resistance and the mechanisms implicated in faecal enterococci from healthy humans, poultry and pets in Portugal. Int J Antimicrob Agents 27: 131-137.
62. Ossiprandi MC, Bottarelli E, Cattabiani F, Bianchi E, (2008) Susceptibility to vancomycin and other antibiotics of 165 Enterococcus strains isolated from dogs in Italy. Comp Immunol Microbiol Infect Dis 31: 1-9.
63. Prescott JF, Brad Hanna WJ, Reid-Smith R, Drost K, (2002) Antimicrobial drug use and resistance in dogs. Can Vet J 43: 107-116.
64. van Belkum A, van den Braak N, Thomassen R, Verbrugh H, Endtz H, (1996) Vancomycin-resistant enterococci in cats and dogs. Lancet 348: 1038-1039.
65. Devriese LA, Ieven M, Goossens H, Vandamme P, Pot B, et al. (1996) Presence of vancomycin-resistant enterococci in farm and pet animals. Antimicrob Agents Chemother 40: 2285-2287.
66. De Leener E, Decostere A, De Graef EM, Moyaert H, Haesebrouck F, (2005) Presence and mechanism of antimicrobial resistance among enterococci from cats and dogs. Microb Drug Resist 11: 395-403.
67. Willems RJ, van Schaik W, (2009) Transition of Enterococcus faecium from commensal organism to nosocomial pathogen: natural ecology of Enterococcus faecium. Future Microbiol 4: 1125-1135.
68. Takeuchi K, Tomita H, Fujimoto S, Kudo M, Kuwano H, et al. (2005) Drug resistance of Enterococcus faecium clinical isolates and the conjugative transfer of gentamicin and erythromycin resistance traits. FEMS Microbiol Lett 15: 347-354.
69. Arias CA, Panesso D, Singh KV, Rice LB, Murray BE, (2009) Cotransfer of antibiotic resistance genes and a hylefm-containing virulence plasmid in Enterococcus faecium. Antimicrob Agents Chemother 53: 4240-4246.
70. Bentorcha F, de Cespedes G, Horaud T, (1991) Tetracycline resistance heterogeneity in Enterococcus faecium. Antimicrob Agents Chemother 35: 808-812.
71. Warburton PJ, Palmer RM, Munson MA, Wade WG, (2007) Demonstration of in vivo transfer of doxycycline resistance mediated by a novel transposon. J Antimicrob Chemother 60: 973-980.
72. Rice LB, Carias LL, Hutton-Thomas R, Sifaoui F, Gutmann L, et al. (2001) Penicillin-binding protein 5 and expression of ampicillin resistance in Enterococcus faecium. Antimicrob Agents Chemother 45: 1480-1486.
73. el Amin NA, Jalal S, Wretlind B, (1999) Alterations in GyrA and ParC associated with fluoroquinolone resistance in Enterococcus faecium. Antimicrob Agents Chemother 43: 947-949.
74. Loeffler A, Boag AK, Sung J, Lindsay JA, Guardabassi L, et al. (2005) Prevalence of methicillin-resistant Staphylococcus aureus among staff and pets in a small animal referral hospital in the UK. J Antimicrob Chemother 56: 692-697.
75. Manson JM, Keis S, Smith JMB, Cook GM, (2003) Characterization of a vancomycin-resistant Enterococcus faecalis (VREF) isolate from a dog with mastitis: further evidence of a clonal lineage of VREF in New Zealand. J Clin Microbiol 41: 3331-3333.
76. Gilmore MS, Coburn PS, Nallapareddy SR, Murray BE, (2002) Enterococcal virulence. In: Gilmore MS, Clewell DB, Courvalin P, Dunny GM, Murray BE, editors. The enterococci: pathogenesis, molecular biology and antibiotic resistance Washington D. C. ASM Press pp. 301-354.
77. Sandoe JAT, Witherden IR, Cove JH, Heritage J, Wilcox MH, (2003) Correlation between enterococcal biofilm formation in vitro and medical-device-related infection potential in vivo. J Med Microbiol 52: 547-550.
78. Tendolkar PM, Baghdayan AS, Gilmore MS, Shankar N, (2004) Enterococcal surface protein, Esp, enhances biofilm formation by Enterococcus faecalis. Infect Immun 72: 6032-6039.
79. Heikens E, Bonten MJM, Willems RJL, (2007) Enterococcal surface protein Esp is important for biofilm formation of Enterococcus faecium E1162. J Bacteriol 189: 8233-8240.
80. Schlievert PM, Gahr PJ, Assimacopoulos AP, Dinges MM, Stoehr JA, et al. (1998) Aggregation and binding substances enhance pathogenicity in rabbit models of Enterococcus faecalis endocarditis. Infect Immun 66: 218-223.
81. Chow JW, Thal LA, Perri MB, Vazquez JA, Donabedian SM, et al. (1993) Plasmid-encoded hemolysin and aggregation substance production contribute to virulence in experimental enterococcal endocarditis. Antimicrob Agents Chemother 37: 2474-2477.
82. Shankar N, Coburn P, Pillar C, Haas W, Gilmore M, (2004) Enterococcal cytolysin: activities and association with other virulence traits in a pathogenicity island. Int J Med Microbiol 293: 609-618.
83. Nakayama J, Cao Y, Horii T, Sakuda S, Akkermans ADL, et al. (2001) Gelatinase biosynthesis-activating pheromone, a peptide lactone that mediates a quorum sensing in Enterococcus faecalis. Mol Microbiol 41: 145-154.
84. Haas W, Shepard BD, Gilmore MS, (2002) Two-component regulator of Enterococcus faecalis cytolysin responds to quorum-sensing autoinduction. Nature 415: 84-87.
85. Eaton TJ, Gasson MJ, (2001) Molecular screening of Enterococcus virulence determinants and potential for genetic exchange between food and medical isolates. Appl Environ Microbiol 67: 1628-35.
86. Biavasco F, Foglia G, Paoletti C, Zandri G, Magi G, et al. (2007) VanA-type enterococci from humans, animals, and food: species distribution, population structure, Tn1546 typing and location, and virulence determinants. Appl Environ Microbiol 73: 3307-3319.
87. Willems RJ, Top J, van den Braak N, van Belkum A, Endtz H, et al. (2000) Host specificity of vancomycin-resistant Enterococcus faecium. J Infect Dis 182: 816-823.
88. Valdezate S, Labayru C, Navarro A, Mantecón MA, Ortega M, et al. (2009) Large clonal outbreak of multidrug-resistant CC17 ST17 Enterococcus faecium containing Tn5382 in a Spanish hospital. J Antimicrob Chemother 63: 17-20.
89. Willems RJ, Top J, van Santen M, Robinson DA, Coque TM, et al. (2005) Global spread of vancomycin-resistant Enterococcus faecium from distinct nosocomial genetic complex. Emerg Infect Dis 11: 821-828.
90. Freitas AR, Novais C, Ruiz-Garbajosa P, Coque TM, Peixe L, (2009) Dispersion of multidrug-resistant Enterococcus faecium isolates belonging to major clonal complexes in different Portuguese settings. Appl Environ Microbiol 75: 4904-4908.
91. Top J, Willems RJ, Bonten MJM, (2008) Emergence of CC17 Enterococcus faecium: from commensal to hospital-adapted pathogen. FEMS Immunol Med Microbiol 52: 297-308.
92. Galloway-Pena JR, Nallapareddy SR, Arias CA, Eliopoulos GM, Murray BE, (2009) Analysis of clonality and antibiotic resistance among early clinical isolates of Enterococcus faecium in the united states. J Infect Dis 200: 1566-1573.
93. Dethlefsen L, Huse S, Sogin ML, Relman DA, (2008) The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol 6: e280.
94. Antonopoulos DA, Huse SM, Morrison HG, Schmidt TM, Sogin ML, et al. (2009) Reproducible community dynamics of the gastrointestinal microbiota following antibiotic perturbation. Infect Immun 77: 2367-2375.
95. Jernberg C, Löfmark S, Edlund C, Jansson JK, (2010) Long-term impacts of antibiotic exposure on the human intestinal microbiota. Microbiology 156: 3216-3223.